Clinical Trials Logo

Cerebral Amyloid Angiopathy clinical trials

View clinical trials related to Cerebral Amyloid Angiopathy.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03464344 Active, not recruiting - Clinical trials for Cerebral Amyloid Angiopathy

Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.

CORELIA
Start date: October 12, 2018
Phase: N/A
Study type: Interventional

Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in the elderly with high risk of recurrence. The investigators aim to determine the relationship between cortical superficial siderosis (cSS), a MRI hemorrhagic marker of CAA and the risk of symptomatic ICH recurrence in a multicentric prospective cohort of patients with acute lobar ICH related to CAA. The investigators hypothesize that patients with cSS have an increased risk of recurrent symptomatic ICH relative to those without cSS.

NCT ID: NCT01856699 Active, not recruiting - Ischemic Stroke Clinical Trials

Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy

SuSPect-CAA
Start date: May 2013
Phase: N/A
Study type: Observational

Aim of the SuSPect-CAA study is to prospectively evaluate the prognostic significance of cortical superficial siderosis in patients with suspected cerebral amyloid angiopathy with a primary focus on future stroke and mortality.